The TRIF/TBK1/IRF-3 activation pathway is the primary inhibitory target of resveratrol, contributing to its broad-spectrum anti-inflammatory effects
| Image |  |
|---|---|
| Description | scientific article published on April 1, 2011 |
| Author/s |
author: Jae Youl Cho |
| Publication date | April 1, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |